| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/27/2002 | WO2001081613B1 Method for the identification of active site protease inactivators |
| 12/27/2002 | WO2001077393A3 Methods for detecting neurological disorders |
| 12/27/2002 | WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof |
| 12/27/2002 | WO2001072123A9 Methods for increasing a cytotoxic t lymphocyte response in vivo |
| 12/27/2002 | WO2001067103A9 Function homology screening |
| 12/27/2002 | WO2001064956A3 The identification and use of effectors and allosteric molecules for the alteration of gene expression |
| 12/27/2002 | WO2001064952A3 Method for reducing artifacts in nucleic acid amplification |
| 12/27/2002 | WO2001056691A3 Method and device for the synthesis and the analysis of support-bound arrays of oligomers, especially of primer pairs for pcr, as well as oligomer-carrying supports |
| 12/27/2002 | WO2001051649A3 Identification of virulence determinants |
| 12/27/2002 | WO2001029262A3 Genotyping reagents, kits and methods of use thereof |
| 12/27/2002 | CA2753372A1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 12/27/2002 | CA2465075A1 Hdac9 polypeptides and polynucleotides and uses thereof |
| 12/27/2002 | CA2451524A1 Templated molecules and methods for using such molecules |
| 12/27/2002 | CA2451465A1 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 12/27/2002 | CA2451074A1 Diagnosis and prognosis of breast cancer patients |
| 12/27/2002 | CA2451067A1 Method for the specific fast detection of bacteria which is harmful to beer |
| 12/27/2002 | CA2451053A1 Method for specific fast detection of relevant bacteria in drinking water |
| 12/27/2002 | CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 12/27/2002 | CA2450831A1 Nucleic acid multiplex formation |
| 12/27/2002 | CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | CA2450704A1 Homology analysis system, homology analysis method, homology analysis program, and transaction establishment system |
| 12/27/2002 | CA2450700A1 Trx1 antibody and uses therefor |
| 12/27/2002 | CA2450666A1 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 12/27/2002 | CA2450610A1 Genomic mapping method |
| 12/27/2002 | CA2450590A1 Methods and compositions for inhibiting, preventing or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 12/27/2002 | CA2450444A1 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
| 12/27/2002 | CA2450164A1 Virus detection method, primers therefor and screening kit |
| 12/27/2002 | CA2450159A1 Methods for modulating gap junctions |
| 12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | CA2449911A1 Amplifiable probe |
| 12/27/2002 | CA2449839A1 Real happy mapping |
| 12/27/2002 | CA2449366A1 Happier mapping |
| 12/27/2002 | CA2449042A1 In silico screening for phenotype-associated expressed sequences |
| 12/27/2002 | CA2448971A1 Chimeric flavivirus vectors |
| 12/27/2002 | CA2446468A1 Selective gene amplification |
| 12/27/2002 | CA2446285A1 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | CA2446284A1 Method for identification of agents for the treatment of diabetes |
| 12/27/2002 | CA2445731A1 Method and nucleic acids for the differentiation of prostate tumors |
| 12/27/2002 | CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/27/2002 | CA2427319A1 Partially double-stranded nucleic acids, methods of making, and use thereof |
| 12/26/2002 | US20020198437 Method of manufacturing a soft hearing aid |
| 12/26/2002 | US20020198371 Nucleotide sequences for use in the detection of polymorphisms in the human genome |
| 12/26/2002 | US20020198369 Nucleotide sequences coding polypeptide for use in treatment of brain, depression, anxiety, epileptic, pain, hypertension, nausea, circadian rhythm, eating/body weight, and sexual/reproductive disorders |
| 12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 12/26/2002 | US20020198366 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/26/2002 | US20020198365 Antibody for use in prevention of prokaryote infections |
| 12/26/2002 | US20020198362 Peptide or polypeptide for use in the diagnosis, prevention and treatment of blood disorders and leukemias |
| 12/26/2002 | US20020198211 cDNA for human methylenetetrahydrofolate reductase and uses thereof |
| 12/26/2002 | US20020198149 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides |
| 12/26/2002 | US20020198148 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides |
| 12/26/2002 | US20020198147 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020197740 Detection of preferential ligand in sample; provide colloidal particles, incubate with sample solution, measure light scatter and/or light absorption, monitor adjustment in light scatter, adjustment in absorption indicates ligand binding |
| 12/26/2002 | US20020197737 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 12/26/2002 | US20020197733 Forming a fluid interface port in a microfluidic system; obtain substrate, form channel with fluid interface aperture, monitor fluid flow through channel |
| 12/26/2002 | US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression |
| 12/26/2002 | US20020197708 Apparatus for use in monitoring the propagation of bacteria in sample |
| 12/26/2002 | US20020197700 Receptor of the EDb-fibronectin domains |
| 12/26/2002 | US20020197693 Novel molecules of the card-related protein family and uses thereof |
| 12/26/2002 | US20020197685 Generation of preferential nucleotide sequences; obtain nucleotide sequences, remove phosphates, remove capping, incubate with nucleotide sequence adaptor, expose to polymerase, amplify recover nucleotide sequences |
| 12/26/2002 | US20020197674 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/26/2002 | US20020197672 Comparative ligand mapping from MHC positive cells |
| 12/26/2002 | US20020197671 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/26/2002 | US20020197666 Human chordin-related proteins and polynucleotides encoding them |
| 12/26/2002 | US20020197663 Evaluation of a pigs ability to metbolize 3-methylindole; obtain metabolites, incubate with aldehyde oxidase, enzyme activity indicate swine abilitiy to metabilize 3-methylindol |
| 12/26/2002 | US20020197662 Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan |
| 12/26/2002 | US20020197658 Detecting modulators of cancer propagation; obtain cell, incubate with modulator, monitor respones to modulator and evaluate cancer propagation |
| 12/26/2002 | US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 12/26/2002 | US20020197653 System for detecting reporter gene expression |
| 12/26/2002 | US20020197649 Catalytic amplification of multiplexed assay signals |
| 12/26/2002 | US20020197648 High throughput screening methods using magnetic resonance imaging agents |
| 12/26/2002 | US20020197642 Primer-mediated polynucleotide synthesis and manipulation techniques |
| 12/26/2002 | US20020197641 Detection regulatory genes; obtain nucleotide sequences, deposit on grid, mutate preferential gene sequences, monitor and evaluate gene expression |
| 12/26/2002 | US20020197640 Mixture for use in the evaluation, monitoring and determination of the phenotype of cells or tissues |
| 12/26/2002 | US20020197639 Methods and products for analyzing nucleic acids based on methylation status |
| 12/26/2002 | US20020197638 Analysis of nicked DNA by matched ion polynucleotide chromatography |
| 12/26/2002 | US20020197636 Appparatus for use in the detection of fluorescence associate with biopolymer sample |
| 12/26/2002 | US20020197634 Fluorescence detecting device, method for producing the same, and fluorescence detecting method employing the same |
| 12/26/2002 | US20020197633 Nucleotide sequence for use in the detection and analysis of gene expression associated with age resistance |
| 12/26/2002 | US20020197632 Diagnosing hypertension in humans; obtain nucleotide sequences sample, incubate with enzymes, hybridize to probe, monitor hybridization pattern, compare to control, evaluate for polymorphisms associated with hyprtension |
| 12/26/2002 | US20020197631 Multichamber device and uses thereof for processing of biological samples |
| 12/26/2002 | US20020197630 Detection of target nucleic acid in a sample; obtain nucleotide sequences, incubate with probes, detect hybridization, recover preferential nucleotidec sequences |
| 12/26/2002 | US20020197629 Isolation of preferential nucleotide sequences; obtain nucleotide sequence sample, applying mixture to separation column, remove targeted nucleotide sequences |
| 12/26/2002 | US20020197628 Detection of ligand which binds to preferential macromolecules; generate crystal of macromolecules, inccubate with ligand, monitor crystal cracking, cracking indicate bound macromolecule |
| 12/26/2002 | US20020197627 Monitoring protein interaction and activities in cell; obtain mating yeast cells, mixing, incubate with modulate, evaluate cell activity |
| 12/26/2002 | US20020197625 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection |
| 12/26/2002 | US20020197623 Solid support for use as tool in nucleotide sequence analysis |
| 12/26/2002 | US20020197621 Methods and compositions for efficient nucleic acid sequencing |
| 12/26/2002 | US20020197619 Assay methods and systems |
| 12/26/2002 | US20020197618 Synthesis and amplification of unstructured nucleic acids for rapid sequencing |
| 12/26/2002 | US20020197617 Aptamers as reagents for high throughput screening |
| 12/26/2002 | US20020197616 Diagnosing crohn's disease; obtain sample of nucleotide sequences, detect adjustment in alleles, presence of deletion indicates crohn's disease |
| 12/26/2002 | US20020197615 Nucleotide sequences coding polypeptide for use as diagnostic tool |
| 12/26/2002 | US20020197614 Gel for use in the analysis of the migration activity of preferential nucleotide sequences |
| 12/26/2002 | US20020197613 Method for the amplification of HLA class I alleles |
| 12/26/2002 | US20020197612 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects |
| 12/26/2002 | US20020197611 Detection of preferential nucleotide sequences in sample; obtain sample, incubate with primers, detect and measure signal |
| 12/26/2002 | US20020197609 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 12/26/2002 | US20020197608 Detection of cancer in humans; obtain saliva sample, extract nucleotide sequences, detect nucleotide sequence mutation, evaluate for cancer |